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The human papillomavirus (HPV) is a DNA virus, which 
belongs to papillomaviridae family, being of low and high risk, 
which infect the skin and mucous membranes and can induce 
benign and malign tumor formation. In the oral mucosa they 
have been associated with oral papilloma, focal epithelial 
hyperplasia, leucoplakia and oral neoplasia. Aim: to study the 
frequency of HPV finding in oral mucosa of normal people. 
Materials and methods: Prospective study, cross-sectional 
cohort. One hundred volunteers, young adults, healthy, aged 
between 20 and 31 years, university students with no history, 
no complains, without oral or oropharyngeal lesions. They 
were submitted to a questionnaire with questions regarding 
HPV infection epidemiology. The samples were harvested 
by brushing and analyzed by PCR. Results: The results were 
negative for HPV in all samples. Conclusion: It seems we had 
high social and economical class individuals, with nutrition 
rich in carotenoyds and vitamin C, low smoking and alcohol 
consumption and heterosexual habits with predominant 
monogamy and regular use of condoms.
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INTRODUCTION
Skin and mucosa are the preferential sites infected 
by the human papillomavirus. HPV is frequently associated 
with benign and malignant neoplasms in the oral cavity, the 
most commonly of which being squamous cell carcinoma. 
The presence of HPV in the epithelium of normal oral 
mucosae, as reported in the literature, does not allow for 
accurate inferences regarding the virus’ role on carcinoge-
nesis, as to whether it is the main etiologic agent, merely 
a secondary force, or simply another inhabitant of the 
oral epithelium. In spite of the improvements introduced 
to oral mucosa HPV detection techniques, the virus direct 
involvement in the appearance of oral carcinomas is yet 
to be definitively proven1. However, considering the HPV 
prevalence rates seen in lesions associated with the virus2, 
its participation in carcinogenesis cannot be ruled out.
The human papillomavirus (HPV) belongs to the 
papillomaviridae genus, papovaviridae family, and has 
a double circular DNA strand with approximately 8,000 
base pairs3. This is a small non-enveloped virus, and its 
genome has its genes coded. Its capsid is icosahedral with 
a diameter ranging between 50nµ and 60nµ; the virus is 
not coated by a lipid envelope; it has 72 capsomeres and 
species-specific antigenic determiners in its outer surface 
and internally. This virus has a double DNA strand divided 
into early (E) and late (L) proteins, and regulating regions. 
The early region (E1-E8) codes genes for viral replication 
and host cell transformation. Proteins E6 and E7 are coded 
for oncogenic HPV types and have been shown to have a 
role in negatively affecting the cell cycle by binding and 
deactivating tumor suppressing genes p53 and pRB. The 
late regions code capsid proteins L1 and L2. L1 is the largest 
capsid and it is highly preserved among the HPV types. 
The long control region (LCR) is a regulating region that 
contains the origin of viral replication that occurs exclusi-
vely in the nucleus of the host cell1,4-7. Depending on the 
composition of these segments, various types of HPV are 
identified with different pathogenic characteristics. Benign 
oral lesions are associated with low-risk HPV types 2, 4, 
6, 7, 11, 13, and 32, with a low potential for evolving to 
malignancy. Malignant oral lesions are associated with 
high-risk HPV types 16, 18, 31, 33, 35, 39, 42, 45, 51, 52, 
56, 58, 59 and 66.8-11 Given the presence of HPV in normal 
oral mucosae in the form of latent infection, the strong 
evidences indicating that benign HPV lesions may evolve 
aggressively and participate in carcinogenesis, the limited 
and often contradictory knowledge on viral behavior on 
normal and diseased individuals, and the evidences to-
wards the increased risk of developing malignant lesions 
among persons infected with high-risk HPV, it is utterly 
important that HPV in the macroscopically normal oral 
mucosa of healthy individuals be researched.
HPV cannot infect us through an intact squamous 
epithelium. In vivo, it infects the basal layer of mitotically 
active skin or mucosa through abrasions or wounds in-
flicted upon the epithelium.12 It is disseminated by direct 
cell-to-cell contact without the classical signs of viremia.13 
After it penetrates the cell, the viral genome is transported 
to the cell nucleus where it is translated and transcribed. 
Viral genome is replicated in the following stages: first, 
early proteins (E1 and E2 are synthesized. As a result of 
that, some 10 to 200 genome copies are replicated per 
cell. In the second stage, during the cell cycle, replication 
occurs in offspring cells at an equal rate. Expression of 
genes E6 and E7 leads to cell transformation or diffe-
rentiation. Cells start presenting a faster life cycle and 
begin to divide more frequently, leading to the formation 
of benign tumors. At this point, the virus proliferates in 
the tissue without destroying the cell hosting it. On the 
third stage, also referred to as the productive stage, large 
amounts of proteins E1 and E2 start producing thousands 
of copies of viral deoxyribonucleic acid (vDNA). On the 
other hand, late proteins (L1 and L2) - fundamental for 
new virus assembly - are also produced. Viruses are then 
released from the keratocyte located more superficially.6,12
In infections by high-risk strains, viral proteins E6 
and E7 - a.k.a. oncoproteins - are highly active and inter-
fere deeply with the cell cycle. This results in faster cell 
division when compared to infections by lower risk strains, 
thus increasing the probability of vDNA being integrated 
to cell genome. Such integration seems to be the cause 
of carcinogenesis.4-6,10
Sexual intercourse is the main mode of transmission 
of HPV.14 When considering transmission to the oral cavity, 
there seems to be a maternal-fetal pathway, while other 
mechanisms may occur after the neonatal period such as 
inoculation through skin lesions onto another individual 
or self-inoculation15,16. Some authors have considered that 
in adults the main pathway for oral HPV infection is oral 
sex17, but the transmission mechanism from the genital tract 
to the oral mucosa and vice-versa is yet to be completely 
clarified. Others consider that genital HPV infection is the 
most frequently observed viral disease among the more 
sexually active portion of the population.18 Studies on 
the concurrent presence of genital and oral HPV found 
the virus on normal mucosal tissue of women with genital 
HPV infection through Southern Blot hybridization (SBH 
- 15.6% - 33/212) and through polymerase chain reaction 
(PCR - 23.1% - 18/78) positive for oral HPV types 6, 11, 
16, and 18.19 No positive results were found for oral HPV 
from samples scraped off of the normal oral mucosae 
of 30 patients with gynecologic HPV confirmed through 
PCR2; males (n=27) with anogenital lesions and without 
oral lesions had no HPV in their oral mucosae. This same 
study reported that in a group of three individuals with 
concurrent anal, genital and oral lesions only one was 
positive for HPV.13
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In terms of carcinogenesis, in situ hybridization was 
performed only to find HPV types 16 and 18 in oral cavity 
squamous cell carcinomas.20 The authors of a literature 
review on oral carcinogenesis found evidences that HPV 
types 16 and 18 are associated with early proteins that bind, 
sequester, and degrade tumor suppressing genes, with 
E6 acting on p53 and E7 similarly upon pRB1. They also 
observed that vDNA was integrated into tumor cells after 
division, indicating their participation in oncogenesis.21,22
Authors looking at changes in eating habits indica-
ted that regular intake of papaya, a fruit rich in carotenoids 
(lutein, zeaxanthin, and β-cryptoxanthin), and citric fruits 
(vitamin C) led to a reduction on the persistence of in-
fection by HPV 23; evidences also indicate that increased 
levels of folic acid reduce the risk of infection for high-risk 
HPV strains.24
According to the literature, prevalence rates of HPV 
in normal oral mucosae vary substantially. Our survey 
found values ranging from 0% to 100%19,25-36, as seen 
on Table 1.
OBJECTIVE
This paper aims to enhance the knowledge on HPV 
epidemiology and  prevalence rates in healthy individuals, 
so that future studies can determine which protection fac-
tors are present in these individuals, which mechanisms 
are in effect and how the virus participates in the genesis 
of tumors, so prophylactic and therapeutic measures are 
developed for the benefit of larger populations.
MATERIALS AND METHOD
This prospective cross-sectional survey was con-
ducted between May 17, 2006 and April 11, 2007. One-
hundred individuals with ages ranging between 20 and 
31 years volunteered to participate in this study. Only 
individuals without previous history, complaints or present 
macroscopic oral cavity and oropharyngeal lesions were 
enrolled. All individuals answered a standard unidentified 
questionnaire numbered based on the collected samples. 
Epidemiologic factors connected to the transmission and 
persistence of HPV infection were addressed, such as 
gender, ethnicity, smoking, alcoholism, use of illicit drugs, 
sexual habits, number of sex partners, use of condoms, and 
eating habits specifically related to foods rich in vitamin 
C (citric fruit) and carotenoids (papaya). After carefully 
examining the individuals oral cavity and oropharynx 
using a photophore, samples were collected from the oral 
mucosa and the mastication sites using an Endobrush® 
brush. Samples were kept in refrigerated sterilized sealed 
numbered packages and sent to the Genic Expression 
Laboratory at the Carlos Chagas Filho Biophysics Institute 
to be analyzed through PCR (polymerase chain reaction). 
PCR was done using primers GP5+/GP6+ and MY09/
MY11 added to the DNA samples along with enzyme Taq 
polymerase, into the reaction compound containing all 
other components required for DNA synthesis. Then the 
reaction compound was placed on a thermocycler and 
submitted to repeated amplification cycles at different 
temperatures following the reaction phases: denaturation 
at 94°C, hybridization at 60°C, and synthesis at 72°C. The 
final product was amplified and analyzed through polya-
crylamide gel electrophoresis. All reactions included a 
negative control (containing all components except for the 
DNA) and a positive control (in which a known standard 
gene was amplified).
This study was approved by the Research Ethics 
Committee at the Clementino Braga Filho University Hospi-
tal and registered before the Scientific Research Committee 
under the following permits: CEP:090/06 and CIC:062/06.
RESULTS
Questionnaire results - sample characterization:
Forty of the 100 individuals enrolled in our study 
were males and 60 were females; 86 claimed to be Cauca-
sian, nine were brown and five were black; ages ranged 
between 20 and 31 years with a mean value of 22.65 
years. In terms of tobacco consumption, 97/100 were non-
smokers and 3/100 were smokers. Alcohol drinking was 
described in the following manner: 31/100 claimed not 
to have any alcohol; 56/100 have alcohol once a week; 
3/100 have alcohol twice a week; 6/100 have it three times 
a week; 4/100 did not respond. Sex habits, as reported: 
100/100 claimed to be heterosexuals; 85/100 have only 
one sex partner; 13/100 have more than one partner; 
69/100 have oral sex; 22/100 do not have sex; 9/100 did 
not respond; 46/100 always wear condoms; 26/100 use 
condoms sometimes; 20/100 never wear condoms; 8 did 
not respond. Consumption of citric foods (vitamin C): 
47/100 have them once a week; 26/100 have citric foods 
twice a week; 15/100 three times a week; 2/100 did not 
respond. Papaya consumption (carotenoids): 29/100 have 
it once a week; 5/100 twice a week; 5/100 three times a 
week; 53/100 do not have it; 8/100 did not respond.
PCR results:
The questionnaire results on sample characterization 
can be seen on Table 2. PCR results were negative for all 
individuals involved.
DISCUSSION
Social-economic factors: anogenital infections by 
HPV appear to be directly connected to social and eco-
nomic variables.14,35,36 Authors have reported that virgin 
adolescents usually do not have detectable levels of anal or 
genital HPV, while those sexually active from earlier ages 
and individuals engaged in prostitution are more prone 
81
Brazilian Journal of otorhinolaryngology 76 (1) January/feBruary 2010
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
to having sexually transmitted diseases, HPV infection 
included. Low levels of HPV infection seem to be related 
to higher social and economic standards observed in the 
European population.37 In our sample, college students 
with average socio-economic status had negative PCR 
test results.
Eating habits: regular consumption of carotenoids 
(lutein, zeaxanthin, and β-cryptoxanthin) and vitamin C 
suggested reduced persistence of HPV infection23 and 
evidences indicate that increased levels of folic acid are 
inversely related to high-risk HPV infection24. In our sam-
ple, consumption of nutrients (vitamin C and carotenoids) 
appeared at a significant rate, as 88% (88/100) claimed 
to have citric foods (sources of vitamin C) between once 
and three times a week and 39% (39/100) stated they have 
papaya (source of carotenoids) between once and three 
times a week. These factors might have contributed to 
reduced prevalence rates of HPV in our sample.
Sex habits: all subjects in our sample claimed to be 
heterosexuals (100%, 100/100). Considering that having 
multiple partners is a factor more frequently found among 
homosexuals, one may assume that heterosexuality has 
contributed to the reduction on the virus prevalence ra-
tes in our sample; however, no specific studies on HPV 
prevalence rates among homosexuals were found. In 
our sample individuals were mostly monogamists, as 6% 
(6/100) claimed to have less than one partner per week, 
85% (85/100) only one partner per week, 5% (5/100) two 
to three partners per week, 2% (2/100) more than three 
partners per week, and 2%(2/100) did not respond. This 
information is reinforced by our results, as 92% (92/100) 
of the subjects claimed to have only one partner per week 
when it comes to kissing the lips of another person. It is 
known that multiple contacts on one same day is rather 
common among young people in our society (thus the 
question was included in the questionnaire). Additionally, 
we must consider the relevance of the reported use of 
condoms; 46% (46/100) claimed they always use it, 26% 
(26/100) use it sometimes. The few individuals - 3% (3/100) 
- who reported to have sex with three partners per week 
and claimed not to wear condoms 1% (1/100) or to wear 
them sometimes - 2% (2/100), also had negative test results 
for HPV. The predominantly monogamist behavior and of 
using condoms by the subjects in our sample may have 
contributed for the absence of HPV positive test results. 
Although 69% (69/100) of the subjects in our sample 
stated they had frequent oral sex, considered by some 
as the principal infection pathway for oral HPV17, many 
authors believe there is no clear or proven link between 
oral sex and greater predisposition to acquiring oral HPV 
infection7,13.
Impact of tobacco and alcohol: differently from what 
was observed in genital cancer38, the impact of smoking 
in the progress of high-risk HPV infection and oral and 
Table 1. HPV in normal oral mucosa of healthy individuals (literature).
AUTHOR
year
Age Range
Collected 
Material
Collection 
Method
Test Total # HPV+ total Tipos de HPV 
Maitland et al, 198725 adults total biopsy hibridização 12 5 41,6% 16
Scully et al., 198726 adults Oral mucosa biopsy hibridização 12 4 41,0% 16
Jenison et al., 199027 adults Oral mucosa scrapes PCR 35 11 31% 6,16
Yeudall, Campo, 199128 adults Oral mucosa biopsy PCR 25 2 8% 18
Jalal et al., 199229 adults oral mucosa scrapes PCR 48 25 52% 16
Kellokoski et al., 199219 adults Oral mucosa biopsy
PCR 
SB
78 
212
18 
33
23,1% 
15,6%
6,11,16,18  
6,11,16,18
Cruz et al., 199630 adults
normal 
gingiva
biopsy PCR 12 0 0%  
Badaracco et al., 199831 adults Oral mucosa scrapes PCR 22 4 18% 6,11,16,31
Schwartz et al, 199832 adults Oral mucosa scrapes PCR 435 39 9%
6,11,16,18,
31,33,35
Smith et al., 199833 adults Oral mucosa lavage PCR 205 10 4,80%
12,16,23,38 
58,72 e não 
classificado
Terai et al., 199934 adults Oral mucosa scrapes PCR 30 30 100% 6,16,18,59 61
Sand et al., 200035 adults Oral mucosa biopsy PCR 12 0 0%  -
Smith et al., 200436 adults Oral mucosa lavage PCR 333 61 10,80% 16,18,31,58
HPV=human papillomavirus
PCR=polymerase chain reaction; SB=Southern Blot hybridization
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oropharyngeal cancer is more controversial, sometimes 
dissociating such factors39, at times seeing increases40 and 
even decreases41-43 in tumor prevalence rates. Although 
some reports indicate that tobacco and alcohol may be 
risk factors for oral and oropharyngeal carcinoma, in-
creased incidence of SCC in populations where tobacco 
and alcohol consumption were reduced for some time 
indicates other risk factors might be at play43. Reinforcing 
this idea, authors reported on male patients with oral and 
oropharyngeal SCC in which the group of heavy smokers 
had lower rates of infection by HPV44.
There seems to be a preventive effect of tobacco in 
oral and oropharyngeal infection by HPV, resulting proba-
bly from increases in keratinization of mucosal surfaces, 
rendering them stronger against minor trauma and less 
susceptible to HPV basal layer cell infection6.
Only 3% (3/100) of the subjects in our sample clai-
med to be smokers, a fact that certainly did not impact 
the results reported.
For alcohol consumption, 32% (32/100) of the sub-
jects claimed they did not drink, 55% (55/100) said they 
had it once a week, 3% (3/100) had it twice a week, 6% 
(6/100) had it three times a week, and 4% (4/100) did not 
respond. Alcohol consumption was therefore reduced and 
of little significance. High alcohol consumption patterns 
seem to work synergistically with high risk HPV infection39, 
a factor not applicable to the studied sample.
Therefore, the impact of tobacco and alcohol con-
sumption upon oral mucosa HPV infection should be 
further clarified.
Persistence of HPV infection and immune aspects: 
infection by HPV takes place at the beginning of sex life, 
somewhere between adolescence and early twenties. In 
most of the cases the infection is transient, and no clinical 
evidence indicates whether the disease can be suppressed 
or eliminated at all, unless immune incompetence sets in. 
Some persistent infections by high-risk virus types may 
evolve to genital cancer. Most of the time, the disease is 
diagnosed between the ages of 25 and 29 years45. There are 
evidences that HPV infection is a transient or intermittent 
phenomenon, with an average duration of 12 months6. 
There seems to be a difference in viral biologic activity 
between men and women, as male subjects tend to have 
more of a fluctuating infection with periods of spontaneous 
remission possibly due to their immune status, local fac-
tors, and the various forms of organization of the genital 
epithelium in both genders13. Our study looked into a 
narrowly aged population (mean age = 22.65 years) of 
both genders (60 females and 40 males), and samples may 
have been collected during a healing period.
Impact of diagnostic tool limitation: there still is 
variation in detection rates, depending on the chosen mu-
cosal sample collection method, namely scrapes, lavages, 
or biopsy and the elected PCR assay46. Although scrapes 
were used and samples were kept refrigerated so as to 
allow for better detection of HPV DNA47,48, this method 
extracts only superficial epithelial cells that are infected 
in subclinical and clinical infection. Therefore, no viruses 
from latent infections in the basal or suprabasal layer cells 
are removed29. Primers MY09 and MY11 and GP5+/GP6+ 
were used in our study, as they are the most routinely 
used in HPV DNA detection and are able to identify a 
wide range of different viruses in one single reaction7,49. 
Reports indicate differences in the results obtained with 
different primers for one same sample, meaning different 
primers amplify different HPV genotypes. Detection of 
mixed infections can only be done by using various pri-
mer pairs in the PCR test50. Considering this limitation, not 
using various primer pairs in our study would increase the 
number of false negative test results. The wide variation 
in prevalence rates observed in various papers may be 
partially explained by the difference found in biopsies of 
normal patients and subjects with lesions in different tests 
(SB and PCR)19. Different tests done on one same group of 
samples could add consistency to comparative analyses. 
Another similar study, however enrolling fewer subjects, 
found positive HPV PCR tests in three patients, while the 
SB of these same patients was negative for HPV17. This 
reinforces the fact that results will depend on the sensiti-
vity of each test.
The existence of local factors, as well as the fact that 
saliva has components that may have a protective effect 
such as lysozymes, lactoferrin, IgA, and cytokines13 could 
explain the low transmission rates through self-inoculation 
and oral sex7.
Although the fact that virus prevalence rates range 
between 0% and 100% in normal individuals indicates the 
possibility that the oral mucosa may work as a reservoir 
of viruses19,34, HPV may be considered as a risk factor for 
oral cancer. Immune disorders could impact HPV infection 
towards latency, cure, or carcinogenesis. HPV types 16 
and 18 - associated with early proteins (E6 and E7) which 
inhibit tumor suppressing genes (p53 and pRB)1  - induce 
increased rates of mitosis, thus enhancing the possibility 
of viral DNA being integrated to cell DNA. Integrated HPV 
DNA found in SCC genome points to the thesis that this 
virus could be an important factor in the etiology of some 
head and neck carcinomas21,22.
CONCLUSION
No traces of HPV were found in our sample based 
on the tests performed in our study. The vast variation 
(0-100%) on HPV prevalence rates found in the oral mu-
cosa of healthy individuals found in the literature may 
indicate that the methods used to detect the virus need to 
be reassessed. It is our belief that more studies should be 
conducted to assist in the development of new methods 
that introduce new elements to clarify how HPV behaves 
in oral mucosa infection.
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